Login
Toggle navigation
Videos
Categories
Trending
Metro Systems Corporation PCL (MSC TB) is a world-class technology company.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Tavit Charuvajana is CEO/Exec Dir at Metro Systems Corp PCL
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Quarterly Market Update: Navigating Bond Losses, Stock Volatility, and Federal Reserve Actions
00:10:00
CEO Christian Sinding Leads EQT's Global Expansion and Sustainability Focus | Christian Sinding, CEO, EQT.
00:10:00
Exploring Cameroon's Gold Potential: A New Frontier in West African Mining
00:10:00
Black Iron Inc: Leading Ukraine's High-Grade Iron Ore Project
00:10:00
Global Market Dynamics: Hyun Song Shin on Liquidity, Leverage, and Macro Risk | Economic Adviser & Head of Research, BIS
00:10:00
Pioneering Japanese CEO's Vision for Personal Health and Preventative Medicine | Kazuo Nakamura, CEO, CMIC Holdings Co Ltd.
00:10:00
Unveiling Africa's Economic Potential: A Conversation with Tony Elumelu | Tony Elumelu, Founder, Heirs Holdings.
00:10:00
Mastering Market Challenges and Expansion: A Conversation with South Africa's Real Estate Chief | Izak Petersen , CEO ,Dipula Income Fund Ltd.
00:10:00
To be a preeminent global investment manager by delivering superior risk-adjusted returns over the long term|Ryan Tolkin,Chief Executive Officer,Schonfeld Strategic Advisors
00:10:00
Invests in next-generation brands|Brian Spaly,General Partner,Brand Foundry Ventures
00:10:00
Invests in innovative food and agriculture companies|Andy Ziolkowski,Managing Partner,Cultivian Sandbox Ventures
00:00:00
Stuart Ashman, CEO, Skinbiotherapeutics